drugset / Trial / NCT04153981
A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in India
NaSingle-groupOpen-labelTreatment
Summary
The reason for this study is to see if insulin glargine is safe in participants with type 2 diabetes mellitus (T2DM) in India.
Timeline
- Start
- 2019-12-16
- Primary completion
- 2021-07-30
- Completion
- 2021-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | insulin glargine | Protein / enzyme biologic | 10 iu | Subcutaneous |